On Jul. 6, 2018, Teva Pharmaceuticals formalized its commitment to consolidate its North America Commercial business areas into New Jersey (NJ) at the company’s global headquarters in Petach Tikva, Israel.

Announced earlier this year as part of a global restructuring process, Teva will establish its North America headquarters in Parsippany-Troy Hills, including more than 1,000 high-wage jobs and the transfer and creation of more than 800 positions. Teva accepted an offer of 10-year, $40 million tax savings incentives from the NJ Economic Development Authority to move forward with its plan to negotiate a lease for office space in the Parsippany-Troy Hills area.

Teva Pharmaceutical is a global leader in generic medicines, with innovative treatments in select areas, including CNS, pain and respiratory. They deliver high-quality generic products and medicines in nearly every therapeutic area to address unmet patient needs.